loader
Please Wait
Applying Filters...
menu
    • menu

    Digital Content for Plazomicin

    Client Email Product
    EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

    Virtual Booth

    Contact Supplier

    Bora Pharmaceuticals- Making success more certain.

    Virtual Booth

    Contact Supplier

    Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.

    Virtual Booth

    Contact Supplier

    Minakem offers CDMO services for API & HPAPI, generics, regulatory expertise, track record performance & FDA & GMP certifications.

    Virtual Booth

    Contact Supplier

    Axplora- The partner of choice for complex APIs.

    Virtual Booth

    Contact Supplier

    Fareva is a one-stop-shop for API/HPAPI, OSD & Sterile products, is USFDA, EMA and PMDA-inspected and has multiple NDA & ANDA filings.

    Virtual Booth

    Contact Supplier

    Menu

    Plazomicin

    ACTIVE PHARMA INGREDIENTS

    PRICE INFORMATION

    FINISHED DOSAGE FORMULATIONS

    DIGITAL CONTENT

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 17,270Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    BIO campaign gathers pharma partners to lobby Congress against superbugs
    BIO campaign gathers pharma partners to lobby Congress against superbugs

    31 Aug 2019

    // Beth Snyder FIERCE PHARMA

    https://www.fiercepharma.com/marketing/bio-campaign-gathers-pharma-and-health-partners-coalition-effort-to-lobby-congress-fight

    Beth Snyder FIERCE PHARMA
    31 Aug 2019
    Share Share
    Key priority is to drive further growth in chronic portfolio: Cipla
    Key priority is to drive further growth in chronic portfolio: Cipla

    12 Aug 2019

    // PHARMABIZ

    http://pharmabiz.com/ArticleDetails.aspx?aid=117467&sid=1

    PHARMABIZ
    12 Aug 2019
    Share Share
    Once picked as a $500M winner, bankrupt Achaogen auctions off its antibiotic
    Once picked as a $500M winner, bankrupt Achaogen auctions off its antibiotic

    07 Jun 2019

    // John Carroll ENDPTS

    https://endpts.com/once-picked-as-a-500m-winner-bankrupt-achaogen-auctions-off-its-antibiotic-for-a-fraction-of-that/

    John Carroll ENDPTS
    07 Jun 2019
    Share Share
    Achaogen cuts costs again and puts up ‘for sale’ sign
    Achaogen cuts costs again and puts up ‘for sale’ sign

    07 Nov 2018

    // Nick Paul Taylor FIERCE BIOTECH

    https://www.fiercebiotech.com/biotech/achaogen-cuts-costs-again-and-puts-up-for-sale-sign?utm_source=internal&utm_medium=rss

    Nick Paul Taylor FIERCE BIOTECH
    07 Nov 2018
    Share Share
    Two Genentech vets reunite at I-O to help steer its $33M drive to the clinic
    Two Genentech vets reunite at I-O to help steer its $33M drive to the clinic

    19 Sep 2018

    // Amber Tong ENDPTS

    https://endpts.com/two-genentech-vets-reunite-at-immune-onc-to-help-steer-its-33m-drive-to-the-clinic/

    Amber Tong ENDPTS
    19 Sep 2018
    Share Share
    Tetraphase plots Q4 launch for 1st antibiotic after OK for eravacycline
    Tetraphase plots Q4 launch for 1st antibiotic after OK for eravacycline

    28 Aug 2018

    // Amber Tong ENDPTS

    https://endpts.com/tetraphase-plots-q4-launch-for-first-antibiotic-after-long-awaited-ok-for-eravacycline/

    Amber Tong ENDPTS
    28 Aug 2018
    Share Share